在血液癌症患者中比较功能和基因组准确医学
Lukas Kazianka1,2, Alexander Pichler1, Christiane Agreiter1
1Department of Internal Medicine I, Division of Hematology and Hemostaseology Medical University of Vienna Vienna Austria.
HemaSphere
|April 25, 2025
概括
基于基因组的精准医学 (gPM) 和功能精准医学 (fPM) 可以指导血液癌症治疗. 这两种策略都可用于临床使用,确定可操作的目标,并为大多数患者提供治疗决策的信息.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 翻译医学是一种翻译医学.
背景情况:
- 精准医学 (PM) 为复发性/耐药性血液癌症提供量身定制的治疗策略.
- 基于基因组的PM (gPM) 和功能PM (fPM) 是领先的PM方法.
- EXALT-2试验调查了gPM和fPM的比较可行性.
研究的目的:
- 评估将gPM和fPM整合到血液癌症患者的临床实践中的可行性.
- 为了比较gPM,fPM和医生选择 (PC) 来得出的治疗建议.
- 评估可操作目标的确定和患者的治疗坚持.
主要方法:
- 在多中心,随机的EXALT-2试验中对55名患者的可行性分析.
- 来自gPM,fPM (基于显微镜和基于流细胞计) 和PC的治疗建议的比较.
- 评估诊断工作流程的实施,推率和接受的治疗.
主要成果:
- 在98%的患者中成功实施诊断工作流程.
- 对76%的患者产生治疗建议;69%的患者接受了建议的治疗.
- 在65%的gPM和80%的fPM中确定了可操作的目标; fPM的报告时间更短.
结论:
- 无论gPM和fPM都可用于血液癌症护理中的临床整合.
- 这些精准医学方法可以指导大多数患者的治疗决策.
- 这项研究强调了个性化治疗策略在血液恶性瘤中的潜力.
更多相关视频
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
10.3K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K